JP2023145581A5 - - Google Patents

Download PDF

Info

Publication number
JP2023145581A5
JP2023145581A5 JP2023119735A JP2023119735A JP2023145581A5 JP 2023145581 A5 JP2023145581 A5 JP 2023145581A5 JP 2023119735 A JP2023119735 A JP 2023119735A JP 2023119735 A JP2023119735 A JP 2023119735A JP 2023145581 A5 JP2023145581 A5 JP 2023145581A5
Authority
JP
Japan
Prior art keywords
amount
pharmaceutical composition
composition
pharma
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023119735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023145581A (ja
Filing date
Publication date
Priority claimed from JP2023530551A external-priority patent/JP7397239B2/ja
Application filed filed Critical
Publication of JP2023145581A publication Critical patent/JP2023145581A/ja
Publication of JP2023145581A5 publication Critical patent/JP2023145581A5/ja
Pending legal-status Critical Current

Links

JP2023119735A 2020-11-20 2023-07-24 インターロイキン－２３受容体のペプチド阻害剤の組成物 Pending JP2023145581A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063116568P 2020-11-20 2020-11-20
US63/116,568 2020-11-20
US202163275222P 2021-11-03 2021-11-03
US63/275,222 2021-11-03
JP2023530551A JP7397239B2 (ja) 2020-11-20 2021-11-19 インターロイキン－２３受容体のペプチド阻害剤の組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023530551A Division JP7397239B2 (ja) 2020-11-20 2021-11-19 インターロイキン－２３受容体のペプチド阻害剤の組成物

Publications (2)

Publication Number Publication Date
JP2023145581A JP2023145581A (ja) 2023-10-11
JP2023145581A5 true JP2023145581A5 (https=) 2025-01-28

Family

ID=88289477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023119735A Pending JP2023145581A (ja) 2020-11-20 2023-07-24 インターロイキン－２３受容体のペプチド阻害剤の組成物

Country Status (1)

Country Link
JP (1) JP2023145581A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025052866A1 (ja) 2023-09-07 2025-03-13 パナソニック インテレクチュアル プロパティ コーポレーション オブ アメリカ アクセスポイント、端末、及び、通信方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107206254B (zh) * 2014-07-17 2021-08-24 领导医疗有限公司 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
MX384213B (es) * 2015-07-15 2025-03-14 Protagonist Therapeutics Inc Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias.
JP7397239B2 (ja) * 2020-11-20 2023-12-12 ヤンセン ファーマシューティカ エヌ．ベー． インターロイキン－２３受容体のペプチド阻害剤の組成物

Similar Documents

Publication Publication Date Title
RU2120798C1 (ru) Твердая фармацевтическая композиция для перорального введения
CN105848647B (zh) 包含azd9291的药用组合物
ES2797493T3 (es) Formulaciones farmacéuticas de liberación controlada de nitazoxanida
ES2380747T3 (es) Métodos y medicamentos para administración de ibuprofeno
JP2012514623A (ja) １またはそれ以上のフマル酸エステルを含む医薬組成物
TW200304379A (en) Pharmaceutical composition
AU2020377451B2 (en) Oral formulation of X842
TW202143997A (zh) 口服藥物組合物
WO2023150500A1 (en) Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof
JP2009507048A5 (https=)
JP2023145581A5 (https=)
JP2024501839A (ja) 腸管洗浄用の経口固形製剤
JP2023510965A5 (https=)
ES2367896T3 (es) Agente para el tratamiento del sindrome del colon irritable con predominio de diarrea.
KR101093781B1 (ko) ｐＨ조절제를 함유하는 목시플록사신 고형 조성물
Katariya et al. Floating Drug Delivery System for Analgesic-A Review
WO2019209217A2 (en) Modified release formulations of flurbiprofen
JP5742352B2 (ja) 解熱鎮痛組成物
ES2558204T3 (es) Formulaciones de comprimido bicapa de flurbiprofeno y glucosamina
US20220125795A1 (en) Therapeutic combinations and compositions for the treatment of inflammatory bowel disease
JP5740896B2 (ja) 解熱鎮痛組成物
KR20260019468A (ko) 위식도 역류 질환(gerd) 치료를 위한 리나프라잔 글루레이트
WO2025163534A1 (en) Crystal form of a peptide inhibitor of interleukin-23 receptor
EA044305B1 (ru) Терапевтические комбинации и композиции для лечения воспалительного заболевания кишечника
WO2010123443A1 (en) Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.